Home | Drugs Approvals and Trials

Drugs Approvals and Trials

The Ottawa Hospital leads first Canadian clinical trial of mesenchymal stem cell therapy for multiple sclerosis

The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation announced today a $4.2 million grant to support the ...

FDA approves first generic esomeprazole

The U.S. Food and Drug Administration today approved the first generic version of Nexium (esomeprazole magnesium delayed-release capsules) to treat gastroesophageal reflux ...

Mount Sinai Launches Artificial Pancreas Research Study

A newly launched clinical research study at the Icahn School of Medicine at Mount Sinai is examining whether an artificial pancreas (AP) can prevent too low blood sugar levels or hypoglycemia in patients with type 1 diabetes (T1D) as they sleep. ... Full story

Malaria vaccine tested at RCSI proves successful in first human trial

Two new malaria vaccines which have undergone a clinical trial in humans, carried out by researchers at RCSI (Royal College of Surgeons in Ireland) in Dublin, have been proven to be well tolerated and produce a strong immune response. The results of the clinical trial are published in the current issue of the journal PLOS ONE. The clinical trial was conducted by researchers at RCSI's Department of International Health & Tropical Medicine at the RCSI Clinical Research Centre in Beaumont Hospital, Dublin, in collaboration with the Jenner Institute at the University of Oxford. The project is funded by the European Vaccine Initiative (EVI) with the support of Irish Aid. ... Full story

National trial first to focus on long-term complications associated with chronic kidney disease, diabetes, hypertension

DALLAS – UT Southwestern Medical Center – in collaboration with Parkland Health & Hospital System, Texas Health Resources, VA North Texas Health Care System, and ProHealth Physicians, Inc. of Connecticut – will lead the first National Institutes of Health-funded, multicenter, clinical trial to address interventions for patients with multiple chronic conditions centered around kidney disease. ... Full story

Study of Generic Antiepilepsy Drugs Finds Minimal Differences

CINCINNATI—A comparison of two of the most disparate approved generic antiepileptic drugs found minimal differences when compared under rigorous testing procedures in people with epilepsy, according to research presented by a University of Cincinnati (UC) clinician-researcher. ... Full story

Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019

Findings Include Response Rates Over 90 Percent in Pediatric Acute Lymphoblastic Leukemia, and First Results of Non-Hodgkin Lymphoma Trial ... Full story

Spaces are still being sought for a first of a kind international study to help women with Polycystic Ovary Syndrome (PCOS)

Spaces are still available for women to take part in a groundbreaking international study looking at whether a drug which helps diabetic patients lose weight could also help them. ... Full story

Booster Ebola vaccine enters first trials at Oxford University

Oxford University scientists have begun testing the safety of a candidate booster vaccine against Ebola, to find out whether it could further increase the immune responses seen in 30 healthy volunteers. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 509 | displaying: 1 - 10